Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Du

Showing results (411-420 of 423) with videos related to

Pageof 43
Sort By:
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|May 25, 2021
[Analysis of low-dose computed tomography compliance and related factors among high-risk population of lung cancer in three provinces participating in the cancer screening program in urban China]Y Wen, L Z Yu, L B Du, et al.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Chinese Journal of Otorhinolaryngology Head and Neck Surgery|December 13, 2016
[Prevalence of hearing disorders in China: a population-based survey in four provinces of China]X Y Hu, X Y Zheng, F R Ma, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|August 26, 2020
[Population's acceptance and attitude toward a novel fecal immunochemical test for colorectal cancer screening: a multi-center survey in China]H Wang, C C Liu, F Z Bai, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|April 3, 2018
[Potential demand on cancer screening service in urban populations in China: a cross-sectional survey]H K Lei, P Dong, Q Zhou, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|March 2, 2018
[Preference on screening frequency and willingness-to-pay for multiple-cancer packaging screening programs in urban populations in China]J Zhu, H Y Huang, A Y Mao, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|March 2, 2018
[Willingness of potential service suppliers to provide cancer screening in urban China]A Y Mao, J F Shi, W Q Qiu, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|March 2, 2018
[Cancer screening service utilization and willingness-to-pay of urban populations in China: a cross-sectional survey from potential service demander's perspective]P Dong, W Q Qiu, J F Shi, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|April 3, 2018
[Constituent and workload of service providers engaged in cancer screening: findings and suggestions from a multi-center survey in China]Z X Sun, J F Shi, L Lan, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|March 2, 2018
[Willingness and preferences of actual service suppliers regarding cancer screening programs: a multi-center survey in urban China]J F Shi, A Y Mao, Z X Sun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2026
Preclinical characterization and phase 1 results of TQB2102, a first-in-class HER2 biparatopic antibody-drug conjugate, in patients with advanced solid tumorsD Y Ruan, S Y Lin, J J Huang, et al.
Pageof 43

Showing results (411-420 of 423) with videos related to

Sort By:
Pageof 43
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|May 25, 2021
[Analysis of low-dose computed tomography compliance and related factors among high-risk population of lung cancer in three provinces participating in the cancer screening program in urban China]Y Wen, L Z Yu, L B Du, et al.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Chinese Journal of Otorhinolaryngology Head and Neck Surgery|December 13, 2016
[Prevalence of hearing disorders in China: a population-based survey in four provinces of China]X Y Hu, X Y Zheng, F R Ma, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|August 26, 2020
[Population's acceptance and attitude toward a novel fecal immunochemical test for colorectal cancer screening: a multi-center survey in China]H Wang, C C Liu, F Z Bai, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|April 3, 2018
[Potential demand on cancer screening service in urban populations in China: a cross-sectional survey]H K Lei, P Dong, Q Zhou, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|March 2, 2018
[Preference on screening frequency and willingness-to-pay for multiple-cancer packaging screening programs in urban populations in China]J Zhu, H Y Huang, A Y Mao, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|March 2, 2018
[Willingness of potential service suppliers to provide cancer screening in urban China]A Y Mao, J F Shi, W Q Qiu, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|March 2, 2018
[Cancer screening service utilization and willingness-to-pay of urban populations in China: a cross-sectional survey from potential service demander's perspective]P Dong, W Q Qiu, J F Shi, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|April 3, 2018
[Constituent and workload of service providers engaged in cancer screening: findings and suggestions from a multi-center survey in China]Z X Sun, J F Shi, L Lan, et al.
Zhonghua Liu Xing Bing Xue Za Zhi = Zhonghua Liuxingbingxue Zazhi|March 2, 2018
[Willingness and preferences of actual service suppliers regarding cancer screening programs: a multi-center survey in urban China]J F Shi, A Y Mao, Z X Sun, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2026
Preclinical characterization and phase 1 results of TQB2102, a first-in-class HER2 biparatopic antibody-drug conjugate, in patients with advanced solid tumorsD Y Ruan, S Y Lin, J J Huang, et al.
Pageof 43